Menarini International Operations Luxembourg
CompanyLuxembourg
Menarini International Operations Luxembourg develops one asset, in phase 3, no development reported (Zofenopril in hypertension). Mostly small molecule; based in Luxembourg.
- 1
- Asset
- Furthest stage
- Phase 3, no development reported
- 7
- Trials
- 0
- Signals
Pipeline
1Inhibits angiotensin-converting enzyme, reducing angiotensin II production and lowering blood pressure.
Phase 3, no development reported, Small molecule, hypertension
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Trials8
- Similar companies6